Table 1.

BrdU labeling of multipotent progenitors in bone marrow and blood after CY/G-CSF mobilization in the presence of BrdU

TissueMultipotent progenitor populationExperiment no.BrdU+ cells/all calls
RatioPercentage
Bone marrow Thy-1.1loSca-1+
Linc-Kit+ 
555/557 99.6 
  354/357 99.2 
  342/347 98.6 
 
   mean 99.1 ± 0.5 
 
Blood Thy-1.1loSca-1+
Linc-Kit+ 
191/194 98.5 
 Thy-1.1loSca-1+
Lin−/loc-Kit+ 
179/183 97.8 
TissueMultipotent progenitor populationExperiment no.BrdU+ cells/all calls
RatioPercentage
Bone marrow Thy-1.1loSca-1+
Linc-Kit+ 
555/557 99.6 
  354/357 99.2 
  342/347 98.6 
 
   mean 99.1 ± 0.5 
 
Blood Thy-1.1loSca-1+
Linc-Kit+ 
191/194 98.5 
 Thy-1.1loSca-1+
Lin−/loc-Kit+ 
179/183 97.8 

Bone marrow (BM) and blood (pooled from 20 mice in experiment 1 and 10 mice in experiments 2 and 3) were obtained from animals treated with BrdU and CY/G-CSF (day + 4) and prepared for flow cytometry. Progenitors were double-sorted onto glass slides coated with tissue adhesive. Cells were lysed, and DNA was denatured and stained with anti-BrdU antibodies, which were visualized by immunofluorescence microscopy (see “Materials and methods”). BrdU+ and BrdU cells were scored, and ratios were made of BrdU+ cells/total cells counted. The mean of the 3 BM experiments is expressed ± SD.

Close Modal

or Create an Account

Close Modal
Close Modal